SPI1 and nonpapillary renal cell carcinoma: SPI1 expression is strongly correlated with immune cell infiltration in clear cell renal cell cancer (ccRCC) and non-responders to anti-PD-1 therapy in the CheckMate 09, 10 and 25 ccRCC trials were more likely to overexpress SPI1 than responders [37].